TGFB1 and neoplasm: Besides, the understanding of cellular and molecular mechanisms of immune checkpoint-based inhibitory pathways may also provide better insight to target different cytotoxic factors such as IL-10, IL-15, VEGF, and TGF-β as well as Siglec-based checkpoints along with T cell and NK-based checkpoint inhibitors for an effective anti-tumor response.